First patient treated with gene therapy targeting ageing cells
5 reported
According to a single-source report from The Guardian, the first person has received a new gene therapy designed to reverse ageing in cells. The treatment targets retinal cells, with the goal of making them behave as if they were young again to improve vision in affected patients. If the therapy proves safe, it could lead to additional treatments based on cellular rejuvenation. The report includes commentary from science editor Ian Sample and Paul Knoepfler, a professor of cell biology and human anatomy at the University of California, Davis.
What’s reported
The first person has been treated with a new gene therapy aimed at reversing ageing in cells.
The trial focuses on retinal cells.
The therapy aims to encourage retinal cells to behave as if young again to improve sight.
If safe, the therapy could open the door to more treatments in cellular rejuvenation.
The report is based on a single source, The Guardian.
Key figures
Ian Sample, science editor (The Guardian)
Paul Knoepfler, professor of cell biology and human anatomy at the University of California, Davis
Sources: The Guardian
